BELLEVUE, Wash., June 28, 2007 — Esterline Technologies Corporation (NYSE: ESL) announced today that, as part of its previously announced consent solicitation relating to its 7.75% Notes due 2013, as of 5:00 p.m. New York City time on June 27, 2007, Esterline had received valid consents from the holders of more than 96% in aggregate principal amount of the outstanding Notes, well in excess of the majority needed to amend the indenture relating to the Notes to permit Esterline's foreign subsidiaries to incur debt in order to reallocate its existing senior secured bank debt to better match its currency funding needs to its revenue sources.
Esterline is a leading world-wide supplier to the aerospace and defense industry specializing in three core areas: Avionics & Controls, Sensors & Systems, and Advanced Materials.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should” or “will,” or the negative of such terms, or other comparable terminology.These forward-looking statements are only predictions based on the current intent and expectations of the management of Esterline, are not guarantees of future performance or actions, and involve risks and uncertainties that are difficult to predict and may cause Esterline’s or its industry’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Esterline's actual results and the timing and outcome of events may differ materially from those expressed in or implied by the forward-looking statements due to risks detailed in Esterline's public filings with the Securities and Exchange Commission.